
Meilan K. Han
Pulmonary Medicine | Intensive Care Medicine
1500 E Medical Center Dr
Floor 3 Reception C
Ann Arbor, MI 48109
Floor 3 Reception C
Ann Arbor, MI 48109
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 520 publications
Tozorakimab to Prevent COPD Exacerbations.
Journal: The New England journal of medicine
Published: September 08, 2026
To the Airway and Beyond: Introduction to an AJRCCM Special Section on Airway Disease.
Journal: American journal of respiratory and critical care medicine
Published: July 08, 2026
Artificial Intelligence-Based Detection of Airway Mucus Plugs on CT and Associations With Clinical Outcomes in COPDGene.
Journal: medRxiv : the preprint server for health sciences
Published: June 29, 2026
Feature-Based Parametric Response Mapping on Thoracic Computed Tomography for Robust Disease Classification in COPD.
Journal: medRxiv : the preprint server for health sciences
Published: May 07, 2026
Diagnostic criteria for invasive pulmonary aspergillosis in COPD patients.
Journal: American journal of respiratory and critical care medicine
Published: April 20, 2026
Survival According to Radiomic and Visual UIP Classification in Fibrotic ILD.
Journal: Chest
Published: April 14, 2026
Astegolimab for chronic obstructive pulmonary disease with frequent exacerbations: pooled analysis of the ALIENTO and ARNASA trials.
Journal: American journal of respiratory and critical care medicine
Published: April 02, 2026
Airway Mucus Plugs in Asthma and COPD: Pathobiology, Imaging, and Implications for Clinical Trials.
Journal: American journal of respiratory and critical care medicine
Published: March 28, 2026
COPD case finding and identification of at-risk individuals: opportunities for early personalized intervention and disease interception.
Journal: Respiratory medicine
Published: March 24, 2026
Exacerbations and Decreased Lung Function Predict Nebulizer Use and Uptake in COPD and Tobacco Exposed Persons With Preserved Spirometry
Journal: Chronic obstructive pulmonary diseases (Miami, Fla.)
Published: March 02, 2026
Safety and efficacy of astegolimab for COPD with frequent exacerbations regardless of baseline blood eosinophil counts (ALIENTO and ARNASA): randomised, double-blind, placebo-controlled, phase 2b and 3 trials.
Journal: Lancet (London, England)
Published: March 02, 2026
Disease modification and progression in pre-chronic obstructive pulmonary disease: an official American Thoracic Society workshop report.
Journal: Annals of the American Thoracic Society
Published: February 03, 2026
Last Updated: 09/26/2026